Evidence map›Paper›PMID 17044014›Full record

ArticleHuman mutation2007

Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness.

Stephen H Tsang, Michael L Woodruff, Lin Jun, Vinit Mahajan, Clyde K Yamashita, Robert Pedersen, Chyuan-Sheng Lin, Stephen P Goff, Thomas Rosenberg, Michael Larsen and 2 more

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. WTAP mediated mScience China. Life sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. New focus on regulation of the rod photoreceptor phosphodiesterase.Current opinion in structural biology · 2021
    Review
  7. Clinical Phenotype ofInternational journal of molecular sciences · 2021
    Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Functional architecture of the retina: development and disease.Progress in retinal and eye research · 2014
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Stephen H TsangBrown Glaucoma Laboratory, Center for Neurobiology and Behavior, Columbia University, New York, New York, USA. sht2@columbia.edu
Michael L Woodruff
Lin Jun
Vinit Mahajan
Clyde K Yamashita
Robert Pedersen
Chyuan-Sheng Lin
Stephen P Goff
Thomas Rosenberg
Michael Larsen
Debora B Farber
Steven Nusinowitz
Columbia University · USUniversity of California, Los Angeles · USDoheny Eye Institute · USGlostrup Hospital · DKUniversity of Copenhagen · DK

Funding

Toward mechanism- and gene-based therapies for retinal degenerationR01EY018213 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Stephen H Tsang · 2008 to 2026
$6.6M
TAMOXIFEN-INDUCED KNOCK-OUT OF A RETINAL GENEK08EY000408 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TSANG, STEPHEN H · 2000 to 2005
$490k
NEI NIH HHS EY004081NEI NIH HHS K08 EY000408NEI NIH HHS R01 EY018213Wellcome Trust
6 · The paper itself

Abstract

Mutations in the beta-subunit of cGMP-phosphodiesterase (PDE6beta) can lead to either progressive retinal disease, such as human retinitis pigmentosa (RP), or stationary disease, such as congenital stationary night blindness (CSNB). Individuals with CSNB in the Rambusch pedigree were found to carry the H258N allele of PDE6B (MIM# 180072); a similar mutation was not found in RP patients. This report describes an individual carrying the H258N allele, who presented with generalized retinal dysfunction affecting the rod system and a locus of dysfunction at the rod-bipolar interface. Also described are preclinical studies in which transgenic mice with the H258N allele were generated to study the pathophysiological mechanisms of CSNB. While Pde6b(rd1)/Pde6b(rd1) mice have severe photoreceptor degeneration, as in human RP, the H258N transgene rescued these cells. The cGMP-PDE6 activity of dark-adapted H258N mice showed an approximate three-fold increase in the rate of retinal cGMP hydrolysis: from 130.1 nmol x min(-1) x nmol(-1) rhodopsin in wild-type controls to 319.2 nmol x min(-1) x nmol(-1) rhodopsin in mutants, consistent with the hypothesis that inhibition of the PDE6beta activity by the regulatory PDE6gamma subunit is blocked by this mutation. In the albino (B6CBA x FVB) F2 hybrid background, electroretinograms (ERG) from H258N mice were similar to those obtained from affected Rambusch family members, as well as humans with the most common form of CSNB (X-linked), demonstrating a selective loss of the b-wave with relatively normal a-waves. When the H258N allele was introduced into the DBA background, there was no evidence of selective reduction in b-wave amplitudes; rather a- and b-wave amplitudes were both reduced. Thus, factors other than the PDE6B mutation itself could contribute to the variance of an electrophysiological response. Therefore, caution is advisable when interpreting physiological phenotypes associated with the same allele on different genetic backgrounds. Nevertheless, such animals should be of considerable value in further studies of the molecular pathology of CSNB.

Indexed as

Disease Models, AnimalAdultAnimalsCyclic Nucleotide Phosphodiesterases, Type 6DNA Mutational AnalysisElectroretinographyFemaleHumansMaleMiceMice, Inbred DBAMice, TransgenicMutationNight BlindnessPhosphoric Diester HydrolasesRetinal DegenerationCyclic Nucleotide Phosphodiesterases, Type 6PDE6B protein, humanPde6b protein, mousePDE6G protein, humanPde6g protein, mousePhosphoric Diester Hydrolases

Identifiers

PMID17044014
PMCPMC2753261
OpenAlexW2093795363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.